ENTITY
Akebia Therapeutics

Akebia Therapeutics (AKBA US)

6
Analysis
Health Care • United States
Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.
more
Exchange Announcement • 14 Oct 2026 19:57

Current Report (Form 8-K | Period ending 2026-10-07)

Exchange Announcement • 06 Aug 2026 04:57

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 06 Aug 2026 04:10

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 30 Jun 2026 20:05

Current Report (Form 8-K | Period ending 2026-06-30)

Exchange Announcement • 23 Jun 2026 04:16

Current Report (Form 8-K | Period ending 2026-06-17)

x